Chargement en cours...
Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
INTRODUCTION: Dalbavancin is a bactericidal lipoglycopeptide active against gram-positives. Its use has been approved for the treatment of acute bacterial skin and skin structure infections (ABSSSI). METHODS: We conducted a narrative review of the literature on the safety profile of dalbavancin. The...
Enregistré dans:
| Publié dans: | Ther Clin Risk Manag |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7997409/ https://ncbi.nlm.nih.gov/pubmed/33790563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S271445 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|